| Metric | შპს ივერმედი | შპს სიაიეს ფარმა | შპს ბერლინ-ჰემი/ა. მენარინი დისთრიბუშენ ჯორჯია | შპს გლობალფარმი |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾45.9m₾47.1m | ₾65.9m₾48.2m | ₾73.0m₾50.5m | ₾74.1m₾70.6m |
| Revenue growth | -2.5% | 36.7% | 44.5% | 4.9% |
| Profitability | ||||
| EBITDA | -₾1.1m₾3.1m | |||
| ₾2.6m₾1.9m |
| ₾12.1m₾13.0m |
| EBITDA margin | -2.4%6.6% | 51.7%47.4% | 3.6%3.8% | 16.4%18.4% |
| Net profit | -₾993k₾4.4m | ₾33.3m₾22.3m | ₾1.8m₾1.5m | ₾5.3m₾9.3m |
| Net margin | -2.2%9.3% | 50.4%46.2% | 2.5%3.0% | 7.2%13.1% |
| Balance sheet | ||||
| Total assets | ₾38.9m₾42.4m | ₾52.8m₾31.8m | ₾15.8m₾27.4m | ₾188.1m₾152.5m |
| Total equity | ₾30.8m₾35.6m | ₾32.8m₾18.4m | ₾10.0m₾10.4m | ₾37.5m₾37.3m |
| ROE | -3.2%12.3% | 101.5%121.1% | 18.3%14.4% | 14.1%24.9% |